[Adipomyokines in children with obesity]. [PDF]
Probl Endokrinol (Mosk), 2023 Burmitskaya YV +4 more
europepmc +1 more source
[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]. [PDF]
Probl Endokrinol (Mosk)Ermolaeva AS, Fadeev VV.
europepmc +1 more source
[Involvement of essential trace elements in the pathogenesis of thyroid diseases: diagnostic markers and analytical methods for determination]. [PDF]
Probl Endokrinol (Mosk)Troshina EA +6 more
europepmc +1 more source
[Pituitary disorders in patients with end-stage chronic renal failure]. [PDF]
Probl Endokrinol (Mosk)Markova TN, Kosova EV, Mishchenko NK.
europepmc +1 more source
[Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism]. [PDF]
Probl Endokrinol (Mosk)Pylina SV +4 more
europepmc +1 more source
[Clinical, hormonal and molecular genetic characteristics of patients with 46,XY disorders of sex development associated with variants in the HSD17B3 gene]. [PDF]
Probl Endokrinol (Mosk)Kalinchenko NY +5 more
europepmc +1 more source
[Highly selective sodium-glucose co-transporter type 2 inhibitor empagliflozin as means of brain protection in conditions of chronic brain dyscirculation]. [PDF]
Probl Endokrinol (Mosk)Simanenkova AV +7 more
europepmc +1 more source
[Replicative and biochemical ageing mechanisms among females with Turner syndromes]. [PDF]
Probl Endokrinol (Mosk)Mikheev RK +5 more
europepmc +1 more source
[Features of glycemic variability in men with different types of obesity]. [PDF]
Probl Endokrinol (Mosk)Sorokin MY +3 more
europepmc +1 more source
[Search for new immunohistochemical and circulating markers of insulinoma]. [PDF]
Probl Endokrinol (Mosk)Yukina MY +7 more
europepmc +1 more source